15 completed, 3 recruiting, 3 terminated, 2 unknown. 23 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 23 | Completed 15, Recruiting 3, Terminated 3, Unknown 2 |
Follow Cellulitis: new trials by email Literature Review of Cellulitis trials Research Report on Cellulitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course' Antibiotics for duration of symptoms, Antibiotics for duration of prescribed course - Urinary Tract Infection, Cellulitis | Phase 4 | Recruiting | Murdoch Childrens Research Institute | 200 | 2026-08-18 | 2026-08-21 |
| Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections Trimethoprim Sulfamethoxazole - Methicillin Resistant Staphylococcus Aureus, Osteomyelitis Acute | Phase 4 | Recruiting | Indiana University | 100 | 2025-05-20 | 2026-07-29 |
| Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial Clindamycin, Standard of care - Skin Infection, Staphylococcal Infections | Phase 4 | Recruiting | Frieder Schaumburg | 100 | 2024-03-15 | 2024-12-09 |
| High-dose Cephalexin for Cellulitis (HI-DOCC) Cephalexin - Cellulitis | Phase 4 | Completed | Ottawa Hospital Research Institute | 454 | 2023-08-30 | 2026-08-03 |
| Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China test product (T) azithromycin capsule and reference product (R) azithromycin capsule "Sumamed®" - Upper Respiratory Tract Infection, Lower Respiratory Infection | Phase 4 | Completed | Peking University People's Hospital | 48 | 2022-11-16 | 2023-11-28 |
| High-dose vs. Standard-dose Cephalexin for Cellulitis Cephalexin, Cephalexin + placebo - Cellulitis | Phase 4 | Completed | Ottawa Hospital Research Institute | 69 | 2021-08-16 | 2025-01-17 |
| Hospital Avoidance Strategies for ABSSSI Dalbavancin - Skin Infection | Phase 4 | Terminated | Washington University School of Medicine | 11 | 2019-03-04 | 2022-12-09 |
| The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown Medicinal honey, Bacitracin - Skin Infection | Phase 4 | Completed | Henry Ford Health System | 17 | 2018-10-25 | 2026-01-07 |
| Penicillin for the Emergency Department Outpatient Treatment of CELLulitis Flucloxacillin, Phenoxymethylpenicillin, Placebo (for phenoxymethylpenicillin) - Cellulitis, Wound Infection | Phase 4 | Unknown | Royal College of Surgeons, Ireland | 414 | 2016-12-01 | 2016-10-04 |
| A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Oritavancin, Warfarin - Acute Bacterial Skin and Skin Structure Infection | Phase 4 | Completed | The Medicines Company | 17 | 2015-09-29 | 2023-12-20 |
| Duration of ANtibiotic Therapy for CEllulitis Flucloxacillin, Placebo (for flucloxacillin) - Cellulitis, Erysipelas | Phase 4 | Terminated | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 151 | 2014-08-26 | 2017-10-10 |
| Adjunctive Clindamycin for Cellulitis: C4C Trial. Flucloxacillin, Clindamycin, Placebo oral capsule - Cellulitis | Phase 4 | Completed | University Hospitals Bristol and Weston NHS Foundation Trust | 410 | 2013-10-01 | 2022-08-17 |
| The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin Daptomycin, Vancomycin - Cellulitis | Phase 4 | Completed | Hospital Universitario Evangelico de Curitiba | 20 | 2012-07-01 | 2015-03-20 |
| Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections Daptomycin, Vancomycin - Cellulitis, Skin Infections | Phase 4 | Completed | University of Cincinnati | 104 | 2012-05-01 | 2014-08-01 |
| Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis Amorolfine (Antifungal), RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal) - Onychomycosis | Phase 4 | Unknown | Pierre Fabre Dermo Cosmetique | 260 | 2009-08-01 | 2009-11-17 |
| Study of Wound Packing After Superficial Skin Abscess Drainage Wound packing, NoPacking - Abscess, Skin Diseases, Infectious | Phase 4 | Completed | NYU Langone Health | 60 | 2008-09-01 | 2011-01-04 |
| Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. Retapamulin Ointment, 1% - Skin Infections, Bacterial | Phase 4 | Completed | GlaxoSmithKline | 60 | 2007-09-01 | 2016-12-28 |
| Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections Daptomycin - Staphylococcal Skin Infections | Phase 4 | Terminated | Novartis | 52 | 2007-01-01 | 2011-03-24 |
| Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections Tigecycline, ampicillin-sulbactam - Skin Diseases, Bacterial | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 550 | 2006-09-01 | 2026-09-15 |
| RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg Penicillin VK, placebo - Cellulitis/Erysipelas of the Leg | Phase 4 | Completed | University of Nottingham | 274 | 2006-07-01 | 2012-07-24 |
Showing 20 of 23. Sign in to see all of them.
Abscess (3) · Infections (3) · Respiratory Tract Infections (2) · Skin Diseases (2) · Staphylococcal Infections (2) · Arthritis, Infectious (1) · Carbuncle (1) · Dermatomycoses (1) · Diabetic Foot (1) · Emergencies (1) · Erysipelas (1) · Folliculitis (1) · Furunculosis (1) · Impetigo (1)
Connective Tissue Diseases (23) · Skin and Connective Tissue Diseases (23) · Suppuration (23) · Inflammation (22) · Pathologic Processes (22) · Pathological Conditions, Signs and Symptoms (22) · Skin Diseases, Infectious (21) · Infections (20) · Bacterial Infections and Mycoses (8) · Bacterial Infections (7) · Gram-Positive Bacterial Infections (6) · Skin Diseases (5) · Skin Diseases, Bacterial (4) · Respiratory Tract Diseases (3) · Staphylococcal Infections (3)
Daptomycin (4) · Cephalexin (3) · Floxacillin (3) · Vancomycin (3) · Clindamycin (2) · Penicillin V (2) · Anti-Bacterial Agents (1) · Antifungal Agents (1) · Azithromycin (1) · Bacitracin (1) · Cefdinir (1) · Ciclopirox (1) · Keratolytic Agents (1) · Petrolatum (1) · Standard of Care (1)
Ottawa Hospital Research Institute (2) · Abbott (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Frieder Schaumburg (1) · GlaxoSmithKline (1) · Henry Ford Health System (1) · Hospital Universitario Evangelico de Curitiba (1) · Indiana University (1) · Johns Hopkins Bloomberg School of Public Health (1) · Murdoch Childrens Research Institute (1) · NYU Langone Health (1) · Novartis (1) · Peking University People's Hospital (1) · Pierre Fabre Dermo Cosmetique (1)
United States (9) · Canada (3) · Ireland (2) · Netherlands (2) · South Africa (2) · Taiwan (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Bangladesh (1) · Brazil (1) · Chile (1) · China (1) · Costa Rica (1) · France (1)
Abel Wakai, MD FRCEM (1) · Adrian Moughty (1) · Bruce Friedman, MD (1) · Chris Luke (1) · Conor Deasy (1) · Frieder Schaumburg, MD (1) · Gary L Darmstadt, MD (1) · George J. Shaw, MD, PhD (1) · Hywel Williams, Professor (1) · James Wood, MD (1) · Jan M. Prins, MD, PhD (1)
PMID 17355677, PMID 19124814, PMID 19222623, PMID 19788787, PMID 22653459, PMID 2292525, PMID 23145952, PMID 24799810, PMID 24842503, PMID 24885384, PMID 24973422, PMID 25605319, PMID 25992781, PMID 27531595, PMID 28314743, PMID 28836993, PMID 29299899, PMID 29869364, PMID 30321312, PMID 31378847, PMID 34039435, PMID 36592299, PMID 438352